Trial intelligence / Profile preview

Pioglitazone for reducing gastric inflammation in Helicobacter pylori-associated gastritis

2005-001218-42Phase 3Completed

Sponsor
Sant'Orsola-Malpighi University Hospital
Start
Nov 2005
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of pioglitazone in gastritis and Helicobacter pylori infection, sponsored by Sant'Orsola-Malpighi University Hospital. Started Nov 2005; status: completed.

02

Drugs

pioglitazone
03

Conditions

gastritisHelicobacter pylori infection

Beyond the preview

Go deeper on 2005-001218-42.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2005-001218-42.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call